Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of 1,3-Propanediol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 1,3-Propanediol SCHEMBL6501208 | 0.94 | — | — | |
| 1,3-Propanediol SCHEMBL15135 | 0.94 | — | — | |
| 1,3-Propanediol SCHEMBL4973361 | 0.94 | — | — | |
| 1,3-Propanediol SCHEMBL8850846 | 0.94 | TSHR (0.50) | — | |
| 1,3-Propanediol SCHEMBL23295934 | 0.88 | — | — | |
| 1,3-Propanediol SCHEMBL5930809 | 0.88 | — | — | |
| 1,4-Butanediol SCHEMBL7877094 | 0.88 | — | — | |
| 1,3-Propanediol SCHEMBL22660195 | 0.88 | — | — | |
| 1,3-Propanediol SCHEMBL22092283 | 0.88 | — | — | |
| 1,3-Propanediol SCHEMBL2530198 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4376807-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING COMBINATION OF SGLT2 INHIBITOR AND DPP-IV INHIBITOR | Unison Pharmaceuticals Pvt. Ltd. (IN) | 2024-06-05 | — | — | EP | claimed |
| WO-2023007511-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING COMBINATION OF SGLT2 INHIBITOR AND DPP-IV INHIBITOR | UNISON PHARMACEUTICALS PVT. LTD. (IN) | 2023-02-02 | — | — | WO | claimed |
| WO-2021260617-A1 | AN IMPROVED PROCESS FOR PREPARATION OF DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE | HIKAL LIMITED (IN) | 2021-12-30 | — | — | WO | claimed |
| US-11033544-B2 | Low-dose triple combination formulation | The George Institute for Global Health (AU) | 2021-06-15 | — | — | US | claimed |
| US-20200306246-A1 | LOW-DOSE TRIPLE COMBINATION FORMULATION | The George Institute for Global Health (AU) | 2020-10-01 | — | — | US | claimed |
| CN-102995075-B | The copper electro-plating method of low internal stress | 罗门哈斯电子材料有限公司 | 2016-12-21 | — | — | CN | claimed |
| WO-2026098996-A1 | ODOR-CONTROL SUPERABSORBENT COMPRISING ACTIVATED CARBON MATERIAL HAVING A TRIMODAL PORE RADIUS DISTRIBUTION | BASF SE (DE) | 2026-05-15 | — | — | WO | disclosed |
| EP-4739697-A1 | PROCESS FOR THE PREPARATION OF DAPAGLIFLOZIN | Zaklady Farmaceutyczne Polpharma S.A. (PL) | 2026-05-13 | — | — | EP | disclosed |
| EP-4514310-A1 | TOPICAL COMPOSITIONS CONTAINING VITAMIN C | Kenvue Brands LLC (US) | 2025-03-05 | — | — | EP | disclosed |
| CN-119325368-A | Topical compositions containing vitamin C | 强生消费者公司 | 2025-01-17 | — | — | CN | disclosed |
| WO-2025008539-A1 | PROCESS FOR THE PREPARATION OF DAPAGLIFLOZIN | Zakłady Farmaceutyczne POLPHARMA S.A. (PL) | 2025-01-09 | — | — | WO | disclosed |
| EP-4487910-A1 | PROCESS FOR THE PREPARATION OF DAPAGLIFLOZIN | Zaklady Farmaceutyczne Polpharma S.A. (PL) | 2025-01-08 | — | — | EP | disclosed |
| WO-2024136185-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASE, COMPRISING SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR AND ANGIOTENSIN Ⅱ RECEPTOR BLOCKER | 주식회사 티에치팜 | 2024-06-27 | — | — | WO | disclosed |
| WO-2008055856-A1 | PROCESS FOR PRODUCING SUPERABSORBENTS | BASF SE (DE) | 2008-05-15 | — | — | WO | disclosed |
| WO-2008055935-A2 | SUPERABSORBENTS HAVING SUPERIOR PERMEABILITY AND CONVEYING PROPERTIES | BASF SE (DE) | 2008-05-15 | — | — | WO | disclosed |
| CN-100345909-C | Composite dispersion and method for producing same | DAICEL DEGUSSA LTD (JP) | 2007-10-31 | — | — | CN | disclosed |
| CN-1678690-A | Composite dispersion and process for producing the same | DAICEL DEGUSSA LTD (JP) | 2005-10-05 | — | — | CN | disclosed |
| CN-1152071-C | High temp. resistant polyurethane polymers | �Ϻ���ͨ��ѧ | 2004-06-02 | — | — | CN | disclosed |
| CN-1342177-A | High temperature resistant polyurethane polymers | DOW CHEMICAL CO (US) | 2002-03-27 | — | — | CN | disclosed |
| WO-2000058252-A1 | HIGH-PURITY 1,3-PROPANEDIOL DERIVATIVE SOLVENT, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2000-10-05 | — | — | WO | disclosed |